Skip to Main Content

Pathology Grand Rounds: October 20, 2022

October 20, 2022
  • 00:00OK. Good afternoon and welcome to
  • 00:04today's grand rounds in pathology.
  • 00:09I would like to introduce today's speaker,
  • 00:13doctor Patricia Dossantos.
  • 00:15A professor and associate chair of
  • 00:18chemistry from Wake Forest University.
  • 00:22Patricia received her bachelor's
  • 00:24at the Federal University of Rio
  • 00:28Grande in Porto Alegre, Brazil.
  • 00:30And then came to the United States to do
  • 00:36a PhD in biochemistry at Virginia Tech.
  • 00:40After completing her PhD,
  • 00:42she stayed at Virginia Tech for
  • 00:45three years as a postdoc associate.
  • 00:47And was then recruited to the
  • 00:50Department of Chemistry at Wake Forest
  • 00:52University as assistant professor,
  • 00:54where she very quickly wrote through
  • 00:57rose through the ranks to full
  • 00:59professor and associate chair.
  • 01:01Throughout her academic development,
  • 01:04Patricia has always been outstanding.
  • 01:07In the year she graduated with her doctorate,
  • 01:11she received the Outstanding Graduate
  • 01:13Student Award at Virginia Tech,
  • 01:15and she was also the commencement speaker
  • 01:19at the graduation ceremony at Virginia Tech.
  • 01:23She further received at Wake Forest the
  • 01:26faculty Excellence in Research award,
  • 01:29the Robert Depth and Deborah
  • 01:31Lee Faculty Fellowship Award,
  • 01:33and the Eureka Faculty Award of
  • 01:36Excellence in Mentoring and Research.
  • 01:38Patricia has published over 60 peer
  • 01:41reviewed papers and book chapters,
  • 01:44she's an editor in methods in molecular
  • 01:47biology and she has had close to
  • 01:50150 invited talks and peer reviewed
  • 01:52posters and platform presentations at
  • 01:55national and international meetings.
  • 01:58She has been funded by two grants from
  • 02:01by the National Science Foundation and
  • 02:04has interdisciplinary research grants
  • 02:07from the North Carolina Biotechnology Center.
  • 02:12In addition to her excellent science,
  • 02:14Patricia is a extremely successful
  • 02:17teacher and mentor.
  • 02:19She teaches 6 biochemistry courses
  • 02:21at Wake Forest.
  • 02:23She has mentored 20 PhD students
  • 02:28and honor students.
  • 02:31She has also mentored 10 postdoc Fellows,
  • 02:34and she has a fantastic track record
  • 02:39of mentoring undergraduate students.
  • 02:41Who do their honour research
  • 02:44thesis in her lab.
  • 02:46So she has mentored over 60 of
  • 02:50these undergraduate students.
  • 02:51Outside of Wake Forest,
  • 02:53she is a reviewer on standing
  • 02:56review panels for NIH,
  • 02:58National Science Foundation
  • 02:59and the Department of Energy.
  • 03:01She has been a session chair at
  • 03:04Gordon Conferences and a session
  • 03:06chair at International Conference
  • 03:08for iron sulfide clusters.
  • 03:10She's an epoch reviewer for many national
  • 03:14and international funding agencies.
  • 03:16Her talk today is entitled The
  • 03:19Synthesis and Dynamic Landscape of
  • 03:22Transfer RNA's Epic transcriptome
  • 03:24and I think we are in for a treat,
  • 03:26so please welcome Patricia Dossantos.
  • 03:33Thanks for the kind introduction
  • 03:36and invitation to come here.
  • 03:39I had a really great time.
  • 03:41Today very special meeting and
  • 03:43talking about women in academia.
  • 03:45Really enjoyed that with
  • 03:48department colleagues.
  • 03:51OK. So what I want to share with you today,
  • 03:55it's my work on T RNA modification.
  • 03:58So in changes on T RNA modifications
  • 04:02and how that has an impact,
  • 04:05but before I do that kind of
  • 04:07like very broad, we know that.
  • 04:11Several biochemical reactions,
  • 04:12they rely on the chemistry afforded by
  • 04:15protein cofactors and then the enzymes
  • 04:18associated with those cofactors.
  • 04:20So among those cofactors,
  • 04:22sulfur containing cofactors are widely
  • 04:24distributed in nature and then they are
  • 04:27actually participate in several lives.
  • 04:28Sustaining reactions like photosynthesis,
  • 04:32respiration, Nigel fixation will not
  • 04:35be here today without those processes.
  • 04:38So the main purpose of my lab is really.
  • 04:42Trying to understand.
  • 04:44Chemical futures for the synthesis
  • 04:47of sulfur containing cofactors,
  • 04:49which are some of the molecules
  • 04:50shown here on this screen,
  • 04:52and so scientists and the
  • 04:54function of those four factors,
  • 04:56so relevant for today's talk,
  • 04:58is the synthesis of Taiwan nucleosides.
  • 05:04You see them out, yeah.
  • 05:05So Tyrone nucleosides that
  • 05:06are present on to your RNA.
  • 05:11So T RNA has, you know,
  • 05:14very well known function as serving
  • 05:16as a dactyl in translation.
  • 05:19Granada reacts with aminoacyl tyranny
  • 05:23synthetase for the attachment of amino
  • 05:26acids to their cognate T RNA molecules
  • 05:29which are then brought to the ribosome
  • 05:33at the ribosomes tier and a interact
  • 05:36with the messenger RNA enabling the
  • 05:38translation of the genetic code and
  • 05:41the by doing so they promote peptide
  • 05:45synthesis or protein synthesis.
  • 05:47What most people don't know is that tyranny.
  • 05:50One, no canonical role,
  • 05:52so like several roles in Atable ISM,
  • 05:55so tyranny molecules,
  • 05:56they have an impact on gene regulation.
  • 05:59They are also able to sense nutrient sensing.
  • 06:02So the relevant to the story that
  • 06:04I'm going to share with you today,
  • 06:06they are mediate a seller
  • 06:09and stress responses.
  • 06:10They can sense UV radiation and
  • 06:13modulate translational capacity.
  • 06:15Under those conditions T RNA is
  • 06:18important for viral replication.
  • 06:20So the example here is that
  • 06:22modified T RNA actually assists
  • 06:25replication of the HIV virus.
  • 06:27And they're involved in other
  • 06:29functions in addition to the
  • 06:32roles of intact tyranny molecules.
  • 06:34In all these processes that I described
  • 06:36to you, fragments of tyranny a,
  • 06:39there are also equally important
  • 06:40in metabolism. They are involved.
  • 06:43They sell proliferation in cancer,
  • 06:45it hosts defense mechanisms.
  • 06:47So fragments of that tyranny is not only
  • 06:52byproducts of degradation of T RNA.
  • 06:55Uh.
  • 06:56So.
  • 07:28The consequences?
  • 07:32OK. I'll keep going for those of you there.
  • 07:39Read tyranny modifications
  • 07:42reported into biological TRN's.
  • 07:45So in the human genome there are
  • 07:47many T RNA genes and then we
  • 07:50what we know is that ternative is
  • 07:52found in the cytoplasm and called
  • 07:54by nuclear genomic information.
  • 07:57It's also modified.
  • 07:59So while the structure of tyranny
  • 08:01and then another subset of
  • 08:03modifications are found on T RNA
  • 08:05that is mitochondria encoded to RNA
  • 08:07and those modifications are are.
  • 08:09Important for translation at
  • 08:11the above processes.
  • 08:14So I typically don't talk a
  • 08:17whole lot about pathology,
  • 08:18but I thought this crowd would be
  • 08:21interested to know that a Baron or
  • 08:24altered accumulation of tyranny
  • 08:26modifications are are associated with
  • 08:29a variety of pathological disease.
  • 08:32So we have mitochondrial disease
  • 08:34that are associated with mutations
  • 08:36on enzymes that are involved in the
  • 08:38synthesis of a T RNA modifications
  • 08:40in the mitochondria you have
  • 08:42disease that are affect.
  • 08:44Neurological defects associated
  • 08:47with cancer and even diabetes.
  • 08:50So the slide is really small.
  • 08:53So the intention here is not for you
  • 08:55to read all the disease that are found,
  • 08:57but you can read more about
  • 08:59this in this Suzuki paper.
  • 09:01This is not my my literature,
  • 09:03but it's a paper from a leading
  • 09:05scientist on the ****** tyranny
  • 09:07modification field and you can get a
  • 09:09good idea of the variety of metabolic
  • 09:13consequences associated with this.
  • 09:15Function of T RNA modifications.
  • 09:18So in a recent review did on in
  • 09:21Dagley has stated that dysfunctional
  • 09:23protein synthesis at the level
  • 09:25of translation elongation,
  • 09:27so at point where T RNA modifications
  • 09:30become relevant is now recognized as
  • 09:33a major pathophysiological driver in
  • 09:36many human disease including cancer.
  • 09:39So this topic of research is really
  • 09:42important and and oftentimes
  • 09:44overlooked one understanding.
  • 09:46A disease phenotype and molecular level.
  • 09:51So the modification of interest that
  • 09:53I want to share with you about is a
  • 09:55modification that it's a 2 by your audience.
  • 09:58It's a modification that involves
  • 10:00sulfur and that you know that's
  • 10:02kind of it's fits into the whole
  • 10:04umbrella of my research program
  • 10:05that we will understand how sulfur
  • 10:07containing cofactors are assembled.
  • 10:09So this modification is found at
  • 10:12the wobble position of tyranny,
  • 10:15so interacts with the last space
  • 10:17on the codon and it's phylogenetic
  • 10:19conserved in all three.
  • 10:21Domains of life and it's present
  • 10:23in terminating codes for glutamine,
  • 10:25lysine and glutamate.
  • 10:27And the importance of this modification
  • 10:30is that introduction of a soul for a
  • 10:33two position of uridine ring allows
  • 10:36canonical base pair formation with
  • 10:38adenine for let's say AAA cordon of lysine.
  • 10:42But also taught totalization of
  • 10:45this modification allows for non
  • 10:47canonical base pair formations.
  • 10:50So in this case the you can base.
  • 10:52Pair with the G so lack of those
  • 10:56modifications that causes, you know,
  • 10:59severe metabolic consequences.
  • 11:01What it's what it's known that is inhuman.
  • 11:03This modification is found both in the
  • 11:06cytosolic T RNA is in the mitochondrial DNA.
  • 11:10Interestingly,
  • 11:11the biosynthetic pathway to modify
  • 11:14terminating the cytosol is different
  • 11:16than the one that is used to synthesize
  • 11:202 thymidine in the mitochondria.
  • 11:22And the mitochondria pathway is similar
  • 11:24to that of what it's found in bacteria
  • 11:27so reinforces the idea that you know,
  • 11:30bacteria was a ancient microorganisms
  • 11:32that had been gold to into ****** cells.
  • 11:36So here's some good examples of
  • 11:39biosynthetic enzymes involved in the
  • 11:41cities of two pyridine and mutations
  • 11:44have been found in those genes
  • 11:46and they are diseased phenotype.
  • 11:48So I'm not really.
  • 11:52A sanitise that studies human disease,
  • 11:55but that's my effort to to connect with
  • 11:57the audience by primary interest is really
  • 12:00trying to understand bacterial metabolism.
  • 12:02And what we know is that in bacteria
  • 12:05lack of two pyridine or mutations in the
  • 12:09the biosynthetic components of tooth
  • 12:11iodine leads to compromise cellular
  • 12:13viability and in some cases including the
  • 12:17organisms that I am interested about,
  • 12:19this pathway is fully essential
  • 12:21for the organization. Survive.
  • 12:23OK, so it's it's an essential
  • 12:25cellular process,
  • 12:26which makes very interesting if you think
  • 12:29about pathogenic bacteria and how you
  • 12:32can discover new metabolic interventions for.
  • 12:37For the treatment of infections
  • 12:40caused by pathogenic so in the
  • 12:43synthesis of new antibiotics.
  • 12:45So that's the story that I
  • 12:48wanted to tell you about how?
  • 12:51My students and I went on this mission
  • 12:54to really understand and identify
  • 12:57the biosynthetic components of two
  • 12:59pyridine and Bacillus subtilis,
  • 13:02and in the work that we have done more
  • 13:04recently to uncover the additional
  • 13:06functions that this modification
  • 13:08may be playing a role in,
  • 13:10in this particular Organism.
  • 13:12So that's the work of two very
  • 13:15talented graduate students in my lab,
  • 13:17I, Catherine Black,
  • 13:18and actually Edwards actually has graduated.
  • 13:21Uh, last month.
  • 13:22So she she's now off to do bigger
  • 13:25and better things in her life,
  • 13:26but I'm grateful for the discoveries
  • 13:28that she made here.
  • 13:29So there are three main points
  • 13:31that I want to convey here on our
  • 13:34study of two pyridine biosynthesis.
  • 13:36It's our experimental approach
  • 13:38to identify biosynthetic enzymes,
  • 13:41the function of two,
  • 13:42two pyridine as a marker or potentially
  • 13:45sensor of so far availability in
  • 13:49Bacillus subtilis and how we.
  • 13:51Understand the biochemical principles
  • 13:53by which those enzymes operate that
  • 13:57restrict and direct their roles
  • 14:00in the sulfur metabolism.
  • 14:05Before I dive in as that,
  • 14:06I wanted to kind of like show you some
  • 14:09key points so you can have an appreciation
  • 14:12for the complexity of studying those
  • 14:14systems at the biochemical level.
  • 14:17So what we know is that in the centers of
  • 14:20Tyler cofactors and I mentioned before,
  • 14:23I'm interested in the cities of all the
  • 14:26biomolecules showing here on this slide.
  • 14:28What we know is that the first staff
  • 14:30on super mobilization is catalyzed by
  • 14:32an enzyme called cysteine disulphide.
  • 14:35So those enzymes they they use a ping
  • 14:38pong mechanism to bind sustain and
  • 14:41convert sustain into alanine and by
  • 14:44doing so they form a covalent sulfur
  • 14:48personified enzyme intermediate.
  • 14:49The sulfur then is transferred to
  • 14:52downstream pathway components involved in
  • 14:55the synthesis of iron sulfur clusters,
  • 14:57tail nucleosides or different vitamins.
  • 15:01As in the case of tyramine, lipoic acid,
  • 15:05biotin, so on and so forth.
  • 15:08But it's a complicated here is that
  • 15:11if you have at least in humans,
  • 15:13you have one single enzyme,
  • 15:15NFS one that is responsible for the
  • 15:17synthesis of all time nucleosides
  • 15:19in the human genome.
  • 15:21So that's that enzyme is found
  • 15:22in the mitochondria.
  • 15:24In some study model systems like E coli,
  • 15:27you also have a primary enzyme and then
  • 15:31the sulfur transfer pathway here is
  • 15:34shared across different pathways, right?
  • 15:37So you have one.
  • 15:38Primary sulfur donor then and then
  • 15:40that sulfur is traffic to different
  • 15:43pathway intermediates and in some
  • 15:45cases those biosynthetic intermediates
  • 15:47are shared as in the case of two five
  • 15:49year adine and moco Biogenesis which
  • 15:53is also a protein called factor.
  • 15:57To complicate things a little bit more,
  • 15:59is that one interest that I had for
  • 16:03many years and I guess that's where
  • 16:05most of my publications come from,
  • 16:07is really trying to understand the
  • 16:09pathway that leads to the synthesis
  • 16:11of iron sulfur clusters,
  • 16:12very essential protein cofactors.
  • 16:14And then what we want to do is like
  • 16:17when we try to deconvolute those
  • 16:19pathways and try to understand
  • 16:22metabolic defects associated with
  • 16:24the initial sulfur mobilization step.
  • 16:26It's quite complex because what we see
  • 16:30is that there are so iron sulfur enzyme,
  • 16:33so enzymes that depend on iron
  • 16:35sulfur cluster for the synthesis of
  • 16:38other sulfur containing metabolites.
  • 16:40So when you disrupt the initial steps on
  • 16:45sulphur mobilization so for instance.
  • 16:48For the synthesis of tyramine,
  • 16:50you don't really know if you're
  • 16:52disrupting the primary route for sulfur
  • 16:55transfer or if you're inactivating a
  • 16:57biosynthetic enzyme that requires an
  • 16:59iron sulfur cluster for its activity.
  • 17:01So you have this intertwined metabolic
  • 17:04pathways that you have dependency
  • 17:06of a super containing cofactor in
  • 17:09the biosynthesis of another super
  • 17:13containing cofactor. OK.
  • 17:16So one primary metabolic.
  • 17:23A component that we look at it's
  • 17:26tyranny and how T RNA is modified.
  • 17:28And this is really great because
  • 17:31on T RNA modification of a pool you
  • 17:35can identify pathways,
  • 17:37enzymes that contain iron,
  • 17:38sulfur clusters and then they would.
  • 17:44Transfer sulfur to the
  • 17:46cities of this cofactor.
  • 17:49So this is an example here.
  • 17:50The mutations that deplete this
  • 17:53modification causes diabetes,
  • 17:55for instance, so and the enzyme that
  • 17:58does that is an enzyme that contains
  • 18:01an iron sulfur cluster you have.
  • 18:04Sometimes I miss the mouse.
  • 18:07You have pathways like the S2
  • 18:09you pathway that do not require
  • 18:12iron super enzymes and then you
  • 18:14have empathy is not shown here
  • 18:16that do not contain sulfur but it
  • 18:19depends on iron sulfur cluster.
  • 18:20So you can interrogate the cells
  • 18:23under different conditions and
  • 18:25you can extract the that tyranny.
  • 18:27And the primary tool that we use
  • 18:29here is to purify those two RNA
  • 18:32molecules and then analyze the relative
  • 18:34abundance of all those nucleosides using.
  • 18:37High resolution mass spectrometry.
  • 18:39So when we do that,
  • 18:40we not only analyze the analyte of interest
  • 18:43as as to you in this particular case,
  • 18:46but we look at the relative levels of
  • 18:48all those different modifications.
  • 18:50This is important because for
  • 18:52instance in the case of two tire
  • 18:55reading that is in this box here this
  • 18:58modification comes along with additional
  • 19:00modifications on the uridine base.
  • 19:03So if we really want to quantify the effects
  • 19:05on the biosynthesis of two thymidine.
  • 19:07We have to quantify all those
  • 19:10different metabolites and understand
  • 19:12the their relative accumulation.
  • 19:16Umm. Another point to consider when
  • 19:19pursuing this analysis is that the levels,
  • 19:22the relative levels of tyranny,
  • 19:23modifications, they vary with growth phase,
  • 19:29growth conditions,
  • 19:30temperatures and so on and so forth.
  • 19:33So the notion that TNA is modified and
  • 19:36now is fully functional to perform roles
  • 19:39in translation is really misleading.
  • 19:42What we know is that there are
  • 19:44degrees of modification that
  • 19:46confined to the functionality.
  • 19:48Of that tyranny and therefore fine
  • 19:50tune the efficiency of translation.
  • 19:53So for instance,
  • 19:55if you grow cells and the
  • 19:58different temperatures,
  • 19:59you can have a different loading
  • 20:02of of modification and that's
  • 20:04interpreted as improving the
  • 20:06rigidity of that anticodon loop.
  • 20:09So you can favor base pairing
  • 20:12information even in a higher temperature
  • 20:14as in the case of the MSU I6A.
  • 20:19You can also see a differential
  • 20:21accumulation of some modifications
  • 20:23under oxidative stress and this is
  • 20:25attributed because some of those
  • 20:27modifications they are dependent
  • 20:29on enzymes that contain iron
  • 20:31superclusters and then those clusters
  • 20:34are susceptible to oxidative damage.
  • 20:36So you can have a different
  • 20:38accumulation as a as a readout for
  • 20:41oxidative stress in those cells.
  • 20:46So, so when it's studying or trying
  • 20:48to assign a different pathways in the
  • 20:51organisms that have not been studied before
  • 20:54the the standard procedure to do that,
  • 20:57it's like you take a pathway that
  • 21:00is well studied and established and
  • 21:01then you start to blast for that
  • 21:04gene in that particular Organism and
  • 21:06then you find equivalent components
  • 21:08that you can make a good assumption
  • 21:10based on sequence analysis. So.
  • 21:12So when we start that that research that's.
  • 21:15Out of the office workflow to fish out those
  • 21:19genes and and to do biochemical experiments.
  • 21:22So but that's not really the case.
  • 21:25So when we compare the pathway found
  • 21:27in E coli that is where we study and
  • 21:30then we're trying to find equivalent
  • 21:33genes in the basal subtilis genome.
  • 21:35We do not find a complete pathway
  • 21:38in terms of all the enzymes are not
  • 21:41really present in some enzymes are
  • 21:44missing suggesting that.
  • 21:45Now you have perhaps an alternate mechanism
  • 21:49to synthesize that same cofactor.
  • 21:52And that's the case here for two pyridine.
  • 21:54So our attempts to search for all
  • 21:58those enzymes here showing red fail.
  • 22:01So that means that imbecile subtilis,
  • 22:03you don't have those pathways like 5
  • 22:06pathway components are completely missing.
  • 22:08So how you go,
  • 22:09how you go from the Sistine,
  • 22:11the sulfur race to the final
  • 22:13enzyme in the pathway was the
  • 22:16question for that particular study.
  • 22:18OK, So what we know is that in the collide.
  • 22:22Those pathways are really well studied.
  • 22:24There's one primary enzyme,
  • 22:26there's three dominant sulfur receptors,
  • 22:28and then sulfur receptors showing
  • 22:30in blue are the ones that Channel
  • 22:32the sulfur to the biosynthesis.
  • 22:34So for example,
  • 22:35if you delete a you get a very distinct
  • 22:39phenotype that is a deficiency of
  • 22:41two pyridine and deficiency of MOCO.
  • 22:44But you don't affect other pathways
  • 22:46in reality actually affect a little
  • 22:48bit because you are disrupting the
  • 22:50equilibrium or so for transfer.
  • 22:51So you actually.
  • 22:52That boost on iron sulfur production
  • 22:54because you don't have that
  • 22:56competition anymore?
  • 22:59What we found, you know very early stages
  • 23:01when I when I joined Wake Forest is that
  • 23:05Bacillus subtilis doesn't contain one
  • 23:07Sistine the sulfur is it contains 4.
  • 23:09So that to us already told that you
  • 23:14know some of those pathways were
  • 23:16different and then by looking at the
  • 23:18genome neighborhood we could get some
  • 23:20insight about their physiological
  • 23:22functions in their particular Organism.
  • 23:25So so far in my lab and also others
  • 23:28in the field.
  • 23:29Have been able to demonstrate the
  • 23:32partnership between assisting the
  • 23:34Sofras and they're still perceptor
  • 23:37and validate their proposed roles
  • 23:39in the centers of tailcoat factor.
  • 23:41So I have done work in some of
  • 23:44those all those proteins,
  • 23:45but what I'm going to concentrate the
  • 23:48talk it's on wire VO&MA they're they're
  • 23:52relevant for two though you're adding.
  • 23:55So as a biochemist,
  • 23:56the first thing that we do is
  • 23:59actually isolate the existing the
  • 24:01Selfridge perform enzyme kinetics.
  • 24:02And some of those initial studies
  • 24:05show very clearly that those enzymes
  • 24:07display very distinct kinetic behaviors.
  • 24:10What it was really interesting.
  • 24:11So those initial assays were done
  • 24:14like most people in the field do.
  • 24:17So everybody at that point would
  • 24:19do just have kinetic reactions
  • 24:21where you react with sustain and
  • 24:24then you measure the half.
  • 24:26Reaction rate through
  • 24:28quantification of sulfide.
  • 24:33What we wanted to do is then
  • 24:36demonstrate that the presence of
  • 24:39the physiological sofa receptor,
  • 24:41so the second service trading this
  • 24:43reaction was a valid SOFA receptor.
  • 24:47And then in this particular case,
  • 24:48the reaction rate in the presence
  • 24:51of the sulfur acceptor enhanced
  • 24:53about over a hundredfold,
  • 24:55so indicating that the sulfur here in
  • 24:58this case was much better in abstracting.
  • 25:02The personal file then
  • 25:04an artificial reductant.
  • 25:08Sure.
  • 25:11Reaction.
  • 25:15Yes, you.
  • 25:20Yeah. So you may want to think there
  • 25:23are very high but the intracellular
  • 25:25level concentration on reduce this
  • 25:27thing in the cells of his 68 micromolar.
  • 25:31So actually that's actually quite nice if
  • 25:35you study kind of like metabolism because
  • 25:39most enzymes they kind of operate around
  • 25:43the KM that they they have you know.
  • 25:45So if the concentration is it OK
  • 25:48that allows the cells to adjust.
  • 25:51The velocity of that reaction because they
  • 25:53are operating around KM and that's the case.
  • 25:56But one thing that you may,
  • 25:57you know, kind of notice is that the
  • 26:00lowest KM here is for a wire VO.
  • 26:03You know one thing that we may want
  • 26:05to postulate like because this enzyme
  • 26:07is so essential in this modification,
  • 26:09so essential maybe the enzyme has
  • 26:11evolved to have a really low KM
  • 26:14to give a preference for,
  • 26:16so for mobilization on that pathway
  • 26:19under conditions that sulfur
  • 26:20is not readily available.
  • 26:25No, no, that's great.
  • 26:30Guys.
  • 26:32Top.
  • 26:40Not this enzyme.
  • 26:41The next enzyme on the pathways
  • 26:44coupled to the hydrolysis of ATP?
  • 26:47Yeah, not, not this particular.
  • 26:50Not any assistant sufferers.
  • 26:53They use POP chemistry to dissolve urate.
  • 26:57And we have done, I have not included
  • 27:00here extensive kinetic analysis to
  • 27:02show this is a ping pong mechanism and
  • 27:05the formation of the personal fide.
  • 27:07It's a mandatory staff.
  • 27:11So as you imagine,
  • 27:12there's a kinetic burst in the
  • 27:15absence of the Super receptor
  • 27:17and then this enzyme actually can
  • 27:20slowly decay to turn over here,
  • 27:22but the presence of the software
  • 27:24sapter enhances over 100 fold
  • 27:26the overall catalytic cycle.
  • 27:35Periodic cells. Similar.
  • 27:39Yeah, it could excel.
  • 27:41So sisting the cell phrase activity,
  • 27:44it's confined to the mitochondria,
  • 27:47so there's only one gene.
  • 27:49And FS1, the activity of this enzyme
  • 27:51is confined to the mitochondria.
  • 27:54And interestingly,
  • 27:55the reactivity of this enzyme is highly
  • 27:58dependent on the presence of the sulfur
  • 28:00acceptor and modulating proteins.
  • 28:02So there's a sulfur mobilization
  • 28:05just coupled to iron metabolism.
  • 28:07So there's a protein.
  • 28:09It's called for taxing the
  • 28:11binds to the sustained,
  • 28:13the suffrage and the binding of the
  • 28:15frataxin to the assisting the surfaces
  • 28:18enhances the rate of sulfur transfer.
  • 28:21And then what it's new now is that.
  • 28:25This reaction is dependent on
  • 28:26the SOFA receptor where iron
  • 28:28sulfur clusters you're bound.
  • 28:29So relevant for pathological behaviors
  • 28:32is there's a disease that's called
  • 28:35Fredericks ataxia that's associated
  • 28:37with mutations in the FRATAXIN
  • 28:40gene and that disrupts not only
  • 28:43iron sulfur metabolism but also
  • 28:45disrupts iron metabolism overall.
  • 28:48So mutation for taxing leads to
  • 28:50mitochondrial iron overload at the
  • 28:52same time you have all the phenotypes.
  • 28:54Associated with iron deficiency
  • 28:56because you are not channeling
  • 28:58the iron to the proper places.
  • 29:01Maybe just deviating, but you know,
  • 29:04hopefully that answers your question.
  • 29:06Yeah, OK.
  • 29:09So what it's quite interesting is
  • 29:11that those super receptor molecules
  • 29:13are quite as specific,
  • 29:15right.
  • 29:15So you have this protein here
  • 29:18stuff view then we have shown
  • 29:20that in the zinc bound form,
  • 29:22so tightly bound zinc,
  • 29:23so the presence of so few enhances
  • 29:26the activity of its partners so fast,
  • 29:30but so few is not able to display
  • 29:33similar behavior to other systems,
  • 29:35the surfaces in Basilius as
  • 29:37well as orthologs.
  • 29:39Listing to sell for race for him
  • 29:41to note here those enzymes are
  • 29:43extremely similar so the E coli
  • 29:45SUV S and Bacillus sub S they
  • 29:48are over 60% identity identical,
  • 29:50yet they cannot cross react so.
  • 29:55And and that's something that it's
  • 29:57an important feature of those
  • 29:59enzymes to guarantee that the
  • 30:01sulfur is channel to the proper
  • 30:04pathway that you were recruiting.
  • 30:06Umm.
  • 30:08So that's not only a specific
  • 30:11feature of self fast.
  • 30:12So this wire the operating that
  • 30:14we we eventually postulated the
  • 30:17dead it's involving 2 pyridine
  • 30:19has its activity enhanced by the
  • 30:21presence of ATP and then we know
  • 30:23that the catalytic competent form
  • 30:25of 80 of MDMA that's higher delays
  • 30:29is the ATP bound form.
  • 30:31So the enzyme has to have ATP bound to
  • 30:35be able to receive the sulfur and then.
  • 30:39Follow the chemical reaction so we
  • 30:42know that this happens out again
  • 30:45through formation of a personal fight.
  • 30:47Intermedia using those labeling
  • 30:49so for 35 assays.
  • 30:54What we also know is that you know
  • 30:56what we are doing in vitro reactions is
  • 30:58important to be mindful and critical
  • 31:00about the reaction conditions and then
  • 31:02whether those reaction conditions mimic
  • 31:05physiological conditions in the cell.
  • 31:07So like I mentioned,
  • 31:09the field is populated with publications
  • 31:12that use DT and that provides a
  • 31:15means to quantify reaction products.
  • 31:17So DT is none are available in the cell.
  • 31:22So most cells use glucose.
  • 31:23I also the activity of those
  • 31:26enzymes in the presence of mutation.
  • 31:29It's very distinct,
  • 31:30yet you can see an enhancement here.
  • 31:34Tell us uh so.
  • 31:35But Tillis doesn't use glutathione,
  • 31:37doesn't make glutathione instead
  • 31:38uses basically PIOS or have a
  • 31:41collaborator in my department that
  • 31:43synthesize facility file for me
  • 31:45facility always a very poor reduction
  • 31:48is even inhibits the reaction in DT.
  • 31:51But pyridoxine is a quite
  • 31:54effective personified reductase
  • 31:56and enhances greatly the rate of a
  • 32:01personified formation and reduction.
  • 32:03And this is staff, but not at this is staff.
  • 32:06So that's what we think it's
  • 32:08happening in the cell.
  • 32:09This is not a unique feature of wire VOC
  • 32:13reactions done with stuff you and so fast.
  • 32:16Also show that in the kinetic
  • 32:19profile here indicates that the rate
  • 32:22of sulfur mobilization is coupled
  • 32:24with the rate of sulfur reduction
  • 32:27on those kinetic schemes.
  • 32:29So next what we wanted to do it's
  • 32:32kind of replicate what we're seeing
  • 32:34in vivo or at least what we are
  • 32:36postulating in in vivo that can we.
  • 32:39So we know establish that where
  • 32:41there was assisting the self rays
  • 32:44and then imma is a sulfa receptor
  • 32:46here in the ATP bound form.
  • 32:48So next we wanted to proceed on the
  • 32:51pathway and validate it and then in
  • 32:53May it's in fact a tire regulates that
  • 32:56can pass on the sulfur to the tier and a.
  • 33:00So the reaction that is proposed here is
  • 33:03that in the first step of the reaction,
  • 33:05so in uridine you typically have oxygen
  • 33:08here which is not a good leaving group.
  • 33:11So the first step on the reaction is
  • 33:13that ventilate the uridine acquisition 2.
  • 33:16So the sulfur can directly attack leading
  • 33:18to the formation of a tooth iodine.
  • 33:21So when we have done those experiments,
  • 33:24yes we can form 2 pyridine in the test tube.
  • 33:28So validating that this is.
  • 33:30As A2 pathway component,
  • 33:31you don't need all the seven
  • 33:34components that we're seeing in E
  • 33:36coli in the pathway is reliant on
  • 33:38the presence of a reducing agent.
  • 33:40So we don't know what step of it reducing
  • 33:44agent it's used but we postulated
  • 33:46it could be a desktop or desktop.
  • 33:49So you can have personal fight attacking
  • 33:51the other related or you can have a
  • 33:54local reduction of that personal fight
  • 33:56so you have 3 sulfide attacking that.
  • 33:58Nevertheless,
  • 33:59so we know and we can validate that
  • 34:03we can go from you to 2π or you.
  • 34:07But I also mentioned to you that this
  • 34:10modification occurs in conjunction
  • 34:14with a modification at A5 position.
  • 34:16So in this case M and M5 as as
  • 34:20to you and in the literature was
  • 34:23proposed that those two pathways
  • 34:25were independent one to one another.
  • 34:28So you could either titillate
  • 34:30your routine 1st and then you
  • 34:32can modify the five position or
  • 34:34you can modify the five position.
  • 34:37And then thiolate seconds.
  • 34:39So what we did here is that we use a T RNA,
  • 34:44a mixture of tyranny a that contain.
  • 34:48Unmodified you and partially modify you
  • 34:51and then we incubating the reaction
  • 34:55and to our surprise we're not able
  • 34:58to detect the synthesis of the fully
  • 35:02modified M&M as to you only to thy urity.
  • 35:06So that initial result suggested
  • 35:09that maybe the pathways are non
  • 35:13independent bifurcated pathways,
  • 35:15maybe there was some sequentiality
  • 35:17on that pathway.
  • 35:18Somehow and then they was only
  • 35:22recognizing the unmodified view.
  • 35:24Um, we?
  • 35:27Took advantage that the availability
  • 35:29of a crystal structure of MMA
  • 35:32from an ortholog Organism that
  • 35:34had the tyranny intermediate,
  • 35:37adenylate intermediate.
  • 35:37So this is the position of distillation.
  • 35:41And so we look at the active side
  • 35:43and what it kind of kind of became
  • 35:47a structured justification for
  • 35:48our results is that are in close
  • 35:51proximity here for this carbon 5
  • 35:54there was a concern venue alanine.
  • 35:57Uh,
  • 35:57that kind of provide a rationale for
  • 36:00why this partially modified tier and
  • 36:02a was not reacting to form 2 pyridine.
  • 36:05So we thought that the phenylalanine
  • 36:08was provided an historical hindrance
  • 36:10not restricting the partially modified
  • 36:13tyranny from entering the active
  • 36:15side and getting tired related.
  • 36:17So kind of the obvious experiment
  • 36:19is to mutate the enzyme and see
  • 36:21if we open up that active side.
  • 36:23Now we can feed a bigger substrate
  • 36:25and that's exactly what we are
  • 36:27able to demonstrate.
  • 36:28Is that mutant, so 55155 in Bacillus,
  • 36:34154 in E coli, but that's the residue.
  • 36:37So if you open up now we can
  • 36:41make M&M so the fully modified.
  • 36:45Modification,
  • 36:47right?
  • 36:49Using this variant form so those
  • 36:51results kind of postulate that at
  • 36:54least in the source of challenge
  • 36:56the pathway for modifications is
  • 36:58sequential where you till late 1st
  • 37:00and then you modify it A5 position.
  • 37:04So you know this work on devices
  • 37:07was very interesting and and
  • 37:09established that but still subtilis
  • 37:12uses a dedicated system to Socrates
  • 37:14and a SOFA receptor to violate a
  • 37:17tyranna at the U34 position and
  • 37:20what we thought here was that the.
  • 37:24This distinctive reactivity provided
  • 37:26sort of an opportunity for alternate
  • 37:29regulation of the pathways involved,
  • 37:32so for mobilization and
  • 37:33biosynthesis of thiol factors.
  • 37:35So by meaning is that you
  • 37:37have a different system,
  • 37:39the surfaces here showing in yellow
  • 37:42and perhaps regulating them at a
  • 37:44different conditions can kind of
  • 37:47regulate specific pathways and
  • 37:49scenario that is completely different.
  • 37:52Than organisms that only have one
  • 37:53assisting the self race right?
  • 37:55Like you have to have a different.
  • 37:59Mechanism to regulate those different
  • 38:00pathways.
  • 38:01So the experiment that we set
  • 38:02ourselves to do it,
  • 38:03it's is if those are so sulfur
  • 38:07containing
  • 38:07pathways, do we see a differential
  • 38:10regulation if we grow cells under
  • 38:14low sulfur versus high sulfur?
  • 38:16So what we did here was that we cultured
  • 38:19both type associate solar cells under
  • 38:22various sulfur concentrations and
  • 38:24then we analyze the relative levels
  • 38:27of those proteins using Western blot.
  • 38:30And So what you can see here is the
  • 38:33relative abundance of wire video is
  • 38:36greatly enhanced under sulfur replete
  • 38:38conditions versus sulfur depleted conditions.
  • 38:43And the same is true for in the MA.
  • 38:48So what we have observed that
  • 38:51both components wire VMA,
  • 38:53they had decrease abundance on on
  • 38:55their sulfur limiting condition.
  • 38:57So if that is the case and then the
  • 39:00other enzymes are not having much
  • 39:04expression what we thought is that
  • 39:06under conditions of Christ sulfur
  • 39:08concentration then this pathway can
  • 39:10proceed and you get accumulation
  • 39:12on the fully modified.
  • 39:14On tyranny and then under
  • 39:17sulfur depleted conditions,
  • 39:18then you don't get as much
  • 39:21as modified to your RNA.
  • 39:23And that's exactly what we have observed.
  • 39:25So from South culture under different
  • 39:28conditions we can analyze the relative
  • 39:32levels of those modifications using
  • 39:34high rates in Ms and we can see a nice
  • 39:37dose dependent effect on the relative
  • 39:41accumulation of this modification.
  • 39:43So put into kind of repeat what I said
  • 39:47before is this is an essential pathway,
  • 39:49an essential modification but
  • 39:51you have a cellular contacts that
  • 39:53you kind of vary in the degree.
  • 39:55Of modification,
  • 39:56and presumably you were making the
  • 39:59tyranny less optimal for translation.
  • 40:05So what we know also from the
  • 40:07literature that under conditions
  • 40:09that tyranny is hyper modified is not
  • 40:12fully functional and an offer often
  • 40:15hyper modified T RNA's target for
  • 40:17degradation and northern blot analysis
  • 40:20showed that tyranny that is carried
  • 40:24this modification has reduced levels
  • 40:27under sulfur depleted accommodations.
  • 40:30By analyzing T RNA we can also
  • 40:34interrogate the relative levels of
  • 40:37modifications that depend on this thing.
  • 40:39The software is not a wire video
  • 40:42and modifications that presumably
  • 40:43depend on on self assess and known
  • 40:46to depend on ebz two other sustained.
  • 40:49The software is in this Organism
  • 40:51remain steady under those conditions.
  • 40:55Yeah, because my lab has
  • 40:57an expertise on iris.
  • 40:58So for Biogenesis we also test the
  • 41:01activity of three different iron
  • 41:02sulfur enzymes to see if those
  • 41:05conditions are affecting iron super
  • 41:07metabolism and that remains the same.
  • 41:09Whereas you know likewise enzymes
  • 41:11that do not depend on iris
  • 41:14superclusters also is an out there.
  • 41:16So if it looks like that sulfur
  • 41:19availability has a targeted effect on
  • 41:22modulating the pathway involving wire VO.
  • 41:26And MDMA and is not really
  • 41:29disrupting other pathways.
  • 41:31So, you know,
  • 41:32in this particular study we
  • 41:35interrogate sulfur availability and
  • 41:37then this modification is known to
  • 41:40be affected by other physiological
  • 41:42conditions and we are now carrying on.
  • 41:47Modification, you know,
  • 41:48analysis of the relative levels on the
  • 41:50different conditions and testing hypoxia,
  • 41:53UV radiation,
  • 41:54heat and cold and interrogating the
  • 41:57whole effect transcriptome TNA epigen
  • 41:59script home in Bacillus subtilis.
  • 42:02We do believe that this is not a
  • 42:04specific phenomenon to Bacillus subtilis,
  • 42:06but it's also observed in other types
  • 42:08of bacteria and we have preliminary
  • 42:10data to show that and it's also known,
  • 42:13well documented for different types of.
  • 42:17Product sales and mammals that you
  • 42:19also have some of the equivalent
  • 42:21cellular responses.
  • 42:24OK. So the so now it's like
  • 42:26the last bit of story that I
  • 42:29want to tell you about this,
  • 42:30our study on why review MMA.
  • 42:33So we know that those
  • 42:36enzymes are very specific.
  • 42:38The results from the biosynthesis
  • 42:40and also sulfur metabolism project
  • 42:43really informed us that other
  • 42:45assisting the sulfur races in this
  • 42:47Organism cannot pick up the job
  • 42:49offer wire VO and rescue those
  • 42:52phenotypes by meaning that wire.
  • 42:54Video is a dedicated sustained
  • 42:56self race to MMA that plays a
  • 42:59role once you tie your routine and
  • 43:02you know stuff asked for instance
  • 43:05cannot be the sulfur source to MMA,
  • 43:08neither all this other system
  • 43:10the soul phrases.
  • 43:11We also have in vivo and in
  • 43:14vitro data to show that the.
  • 43:17The dedicated role,
  • 43:19it's actually mutual because so
  • 43:22few cannot cross react with our
  • 43:24view and so on and so forth.
  • 43:26So we wanted to understand what are
  • 43:29the structure features on those
  • 43:31enzymes that are really regulating
  • 43:34their physiological functions.
  • 43:35So one way to approach that is
  • 43:38actually to cost compare the
  • 43:40closest ortholog to wire view which
  • 43:43is the E coli ISS, so those two.
  • 43:47Proteins there are about 63%
  • 43:49similar to each other,
  • 43:51but yeah they cannot cross
  • 43:53complement in vivo.
  • 43:55So by meaning that if we transform and
  • 43:58express wire view and an E coli cell,
  • 44:00I cannot rescue the phenotype
  • 44:03associated with ISS.
  • 44:05So this was kind of like part of
  • 44:08a a initial work where we can
  • 44:11do those cross complementation
  • 44:13and expression of wires.
  • 44:15The old the vessel assisting the
  • 44:17sofras cannot react cross react
  • 44:19with us A and rescue their pathway.
  • 44:21But if we Co express both vessels
  • 44:24operating in an ISS knockout of equal life,
  • 44:27we can fully rescue.
  • 44:29The same is true for admission in the MA.
  • 44:33We can only rescue if we express.
  • 44:36This pathway.
  • 44:39At the same time,
  • 44:40so that tells us there's a specific
  • 44:43sulfur transfer from wire video to MMA,
  • 44:46and that sulfur transfer event
  • 44:49cannot happen as prevented somehow
  • 44:52from wire reveal to Tuesday
  • 44:54to rescue that ecoli pathway.
  • 44:57So that kind of provide the premise for
  • 45:00a series of biochemical experiments
  • 45:02where we test the cross reactivity
  • 45:05of those enzymes in the test tube.
  • 45:08So again via video enhances the catalytic
  • 45:11activity of its physiological partner,
  • 45:15but it does not react with the ecoli
  • 45:18ortholog and then the ecoli system.
  • 45:21The suffrage can only have its
  • 45:23activity enhanced in presence
  • 45:25of its geological partner,
  • 45:26the.
  • 45:27Why are video doesn't display
  • 45:31that phenomenon so?
  • 45:32We know those enzymes are catalyzing
  • 45:35the same chemical reaction
  • 45:36which is sulfur transfer from
  • 45:39cysteine to a sulfur receptor.
  • 45:41And then we took advantage of a
  • 45:44crystal structure that was available
  • 45:46in of ecoli ICS in complex where
  • 45:49Texas A and we match the residues
  • 45:52that were at this binding interface.
  • 45:56And we postulated that perhaps
  • 45:59the lack of cross reactivity of
  • 46:02the Bacillus assisting the sulfur
  • 46:04ace in E coli was associated with
  • 46:07a now third
  • 46:08binding interface.
  • 46:11So what we did here is
  • 46:13to guide those analysis.
  • 46:14We conducted a multi sequence
  • 46:17alignment using several sequences of ice.
  • 46:20So this is just an example here.
  • 46:21But several sequences of organisms
  • 46:24that contain ISS like enzymes and
  • 46:26use staff as partners and in several
  • 46:29organs that contain wire veal like
  • 46:31enzymes and use and then MA as
  • 46:34sort of an abbreviated pathway.
  • 46:36And then we try to map residues that
  • 46:38were shared within those groups but
  • 46:40there were distinct between those two.
  • 46:42Families of assisting the cell for assist.
  • 46:44So although they have a high
  • 46:46degree of similarity,
  • 46:48there were some key differences in.
  • 46:50I want to point here on this table.
  • 46:52So what do you see is that?
  • 46:56And it's very interesting is
  • 46:58that some of the residues that
  • 47:00are at the binding interface,
  • 47:03we thus say for instance glutamate 48
  • 47:07and 49 in ecoli had opposite charge
  • 47:10in the wire video sequence and that
  • 47:14provide the basis for a proposal
  • 47:16that those proteins were not cross
  • 47:19reacting because they were not having
  • 47:22a complementary charge afforded by that.
  • 47:25Surface.
  • 47:26Also important to note here is that
  • 47:30this binding interface between
  • 47:33ISIS and Tus 8/6 as I remote.
  • 47:38So the active site is here and you
  • 47:40have a loop that swings into the
  • 47:43active side and donates the sulfur.
  • 47:45So the binding interface between
  • 47:47the enzyme and the sulfur receptor
  • 47:50occurs at remote site and actually
  • 47:52at a different sub unit where
  • 47:55the catalytic chemistry is.
  • 47:56Company,
  • 47:58OK.
  • 47:59So the obviously experiment that
  • 48:01we set up ourselves to do is like
  • 48:04construct a library of mutants and
  • 48:06trying to take wire video and convert
  • 48:08into ISS like by modifying those
  • 48:11select residues into residues that
  • 48:14are present in ISS and see if we
  • 48:17can expand the reactivity of this
  • 48:20enzyme towards equalized so for acceptors.
  • 48:24So we first passed the reactivity
  • 48:26towards the native effectors and
  • 48:28you know some of those residues
  • 48:30here they lost the ability to
  • 48:33engage with the native acceptor,
  • 48:35but most importantly.
  • 48:38By doing this music Genesis studies
  • 48:41we could screen that some of
  • 48:44those mutations so 44, so R44E.
  • 48:49Why are VOC?
  • 48:52The head contain equivalent mutation here.
  • 48:54So when we mutated to look like ISS
  • 48:59now we can engage in a reaction with
  • 49:04pasta and have these activities
  • 49:06stimulation to you know over tenfold
  • 49:10on the catalytic turnover rate and
  • 49:13this is another super receptor.
  • 49:16I that we don't have a crystal
  • 49:18structure for the complex,
  • 49:20but when we mutate 4 residues at
  • 49:22that particular binding interface,
  • 49:24we observe a high degree of extenuation,
  • 49:28so suggesting that we are kind of.
  • 49:32Who were somewhat successful
  • 49:34in engineering those enzymes to
  • 49:36now adopt in a very intentional
  • 49:39mariner expanded reactivity towards
  • 49:42selected pathways.
  • 49:43So to validate some of those findings,
  • 49:47what we did here is that we.
  • 49:50We wanted to determine whether or not
  • 49:54those variant enzymes were able to
  • 49:58partake role on ISS pathways in vivo.
  • 50:02So to do that work we use a ISS knockout
  • 50:06strain and we know that this
  • 50:09is spraying is affected in its
  • 50:12ability to make four thought errity
  • 50:15in a pathway that depends on π,
  • 50:18and it's also affected in a pathway.
  • 50:21To make 2 thyroxine in a through
  • 50:24through engagement with us a.
  • 50:27When we express the wall
  • 50:29type of stimulus enzyme,
  • 50:31we don't really rescue those pathways,
  • 50:33so this is relative levels to
  • 50:36the wall type equalized strain.
  • 50:38However, when we take the
  • 50:40single point mutation R44E,
  • 50:44what we're able to achieve is fully
  • 50:47recovery of two pyridine pathway
  • 50:50indicating that it took only one single
  • 50:54amino acid substitution to convert via VOA.
  • 50:57Into an ISS like enzyme in the pathway
  • 51:02requiring to say those results are
  • 51:03kind of in agreement with the system,
  • 51:05the self race because that's the mutant
  • 51:08that we could show activity stimulation.
  • 51:10Likewise this wire deal quadruple
  • 51:13mutant here could engage with I,
  • 51:16I and recovery if not even more
  • 51:19accumulation of 4th iritty.
  • 51:21And that's a pathway that depends on thi.
  • 51:24This mutant again was a mutant that
  • 51:26showed a 20 fold activity stimulation.
  • 51:29So we're really pleased with this and
  • 51:33kind of struck by the results that
  • 51:36you know it takes only one change
  • 51:38for for a gain of functionality.
  • 51:41We also look at in terms of
  • 51:45growth phenotypes.
  • 51:46So ISS is involved with so
  • 51:49many cellular processes.
  • 51:51Inactivation of ISS causes
  • 51:54a severe growth phenotype.
  • 51:56If we express the wall type,
  • 51:58it doesn't really help,
  • 52:00it actually makes worse.
  • 52:01But expression of that single
  • 52:04mutant partially recovers ISS.
  • 52:07We didn't observe full recovery
  • 52:09in relation to the wild type and
  • 52:12that's actually expected because
  • 52:15we're selectively recovering one of
  • 52:17the pathways that ICS participate.
  • 52:19So in the end, you know my background,
  • 52:23other pathways involving ISS,
  • 52:24they still depleted and contributing
  • 52:28to growth,
  • 52:29growth rates in this particular Organism.
  • 52:34OK.
  • 52:34So with that,
  • 52:35I don't know how I'm doing with time,
  • 52:38but the main take away points that
  • 52:41I want you to kind of remember
  • 52:44from from this talk is that T RNA
  • 52:47performs multiple roles besides
  • 52:49translation and those roles are really
  • 52:51important that defects on enzymes,
  • 52:54they modify T RNA and like some
  • 52:56some folks in the field they
  • 52:59call riders TNA writers,
  • 53:00they are associated with multiple
  • 53:03pathologies and cellular viability.
  • 53:05That the abundance of those
  • 53:07modifications are impacted by
  • 53:09nutrient availability and then
  • 53:11I showed you the example about
  • 53:13sulfur concentration but also their
  • 53:15environmental factors that fine-tuned
  • 53:17the functionality of transfer RNA.
  • 53:20Then in Bacillus subtilis at
  • 53:22least those modifications they
  • 53:25involve dedicated enzymes and the
  • 53:28interaction between the assisting
  • 53:30the surprises and they are sulfur
  • 53:33receptor partners is a very specific.
  • 53:35Event that directs sulfur to the
  • 53:39pathways they're participating.
  • 53:41And then with that,
  • 53:42I want to thank the people that have
  • 53:45done the work. I have a very young lab.
  • 53:48You may recognize the last name here.
  • 53:50So nick?
  • 53:54It was a member of my lab, he graduated.
  • 53:56But I I'm very thankful for all the
  • 53:59students that, graduate and
  • 54:01undergraduate students that and
  • 54:04are in the lab doing hard work,
  • 54:06and also my collaborators that.
  • 54:11Very important for other projects that
  • 54:13I have not talked to you about it.
  • 54:15I'm also thankful for the National
  • 54:17Science Foundation that has been mainly
  • 54:20funded this this project and other
  • 54:22projects in my lab since they started
  • 54:25and then thank you for your attention.
  • 54:31It's time for a public question.
  • 54:36Chat.
  • 54:42Yeah.
  • 54:47Oh, I'm sorry. So so
  • 54:51how do I close? You know the first point.
  • 54:56The modification was carried
  • 54:57in the non canonical function.
  • 55:01Umm.
  • 55:04OK. So let's do that. Uh.
  • 55:09There we go. OK. Sorry.
  • 55:14Curated.
  • 55:17Partner talk. Are the modifications to the
  • 55:21modifications of the tyranny that dictate the
  • 55:23other the other problems like in viral?
  • 55:28Yeah. Directs the.
  • 55:32So you know that's a really great
  • 55:35one because for example tyranny
  • 55:37lysine and it's modified form is
  • 55:39actually a primer for HIV replication.
  • 55:42So that modification is really important.
  • 55:45I think the work that I just showed
  • 55:48you in its modified form and then the
  • 55:50work that I kind of show you here
  • 55:52also kind of sides to that because the
  • 55:55unmodified form is targeted for degradation.
  • 55:57So I think you know for you guys
  • 56:00that you know the pathology and.
  • 56:03You know, I think there's a great
  • 56:04deal of appreciation on, you know,
  • 56:06let's run next gene sequencing transcriptome
  • 56:09and then getting a proteome analysis.
  • 56:14I think would be great.
  • 56:16You also have the eppi tyranny transcriptome
  • 56:18in some of those disease phenotypes right?
  • 56:21Like I bet you will be altered.
  • 56:24There are different modifications
  • 56:26like cuisine is one that it's highly
  • 56:30evolved on nutritional status and
  • 56:32in associated with a whole slew
  • 56:35of different disease phenotypes.
  • 56:37So. How they do so? One way is.
  • 56:45Depending on the seller response.
  • 56:48T RNA is playing a role
  • 56:51because expression of genes,
  • 56:53for example stress response.
  • 56:55It is known that genes involved in
  • 56:59stress response they have a codon bias,
  • 57:02so codons that require TNA that is
  • 57:05modified are necessary for translation
  • 57:08of those of those proteins and evolving
  • 57:12in stress response for diabetes,
  • 57:15for instance the MS2I6A.
  • 57:19What was known is that
  • 57:21for insulin translation.
  • 57:23You require you have a codon bias towards
  • 57:26T RNA that carries that modification.
  • 57:29So if you don't have the modification,
  • 57:32then you're compromising translation of
  • 57:35of the proteins that depend on that.
  • 57:38Does that make sense?
  • 57:40Yeah, good question.
  • 57:48See any of the benefits
  • 57:50that you described utilized
  • 57:52development for material, yeah.
  • 57:54So there there's a good understanding
  • 57:57much more on the operatic front.
  • 57:59But for a bacteria,
  • 58:00I think there has been some attempts,
  • 58:02especially for modifications that
  • 58:05are essential to target the.
  • 58:08To target those writers,
  • 58:10like tyranny writers,
  • 58:12as a mechanism to hold.
  • 58:16So viability but that is
  • 58:20still kind of in its infancy.
  • 58:23There's a great deal of interest
  • 58:25more recent one up maybe targeting
  • 58:27the system itself races because they
  • 58:30have they are so specific right.
  • 58:33So if you can just drop the function of
  • 58:35those sustained itself races and that's
  • 58:37specific super transfer event then you
  • 58:40selectively inhibit those enzymes.
  • 58:42So I don't really do drug
  • 58:44development you know my research.
  • 58:46Like as you can tell is more
  • 58:49kind of fundamental basic science
  • 58:51understanding biochemical pathways.
  • 58:52But hopefully you know they're being
  • 58:56interested from pharmaceutical companies
  • 58:58on talking about let's trying to
  • 59:00find an inhibitor especially liking
  • 59:02but still is and other gram positive
  • 59:04because you have multiple enzymes and
  • 59:06then they have very specific phenotypes.
  • 59:08Can we find any inhibitor that binds to
  • 59:11like only so fast that is found in Gram
  • 59:14positive as a specialized drug development.
  • 59:16So antibiotic that targets only
  • 59:19grandparent grand positive pathogens.
  • 59:21Yeah.
  • 59:27Good, OK.